The UAB Neurofibromatosis Clinic functions as a multidisciplinary team led by Dr. Bruce Korf and Dr. Lane Rutledge, who have extensive experience in caring for patients with this condition. Clinic staff include genetic counselors and nurses, as well as access to specialists as needed. The clinic serves patients and their families dealing with the lifelong medical, psychological, and social implications of this diagnosis. Involvement in clinical research or clinical trial is possible in some instances. For more information:Understanding Neurofibromatosis type 1 (NF1)
Understanding Neurofibromatosis type 2 (NF2)
Genetic Testing for NF
The University of Alabama at Birmingham (UAB) is launching a clinical trial for qualified individuals with a diagnosis of Neurofibromatosis type 1 (NF1).
A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis type 1 related Plexiform Neurofibromas
Progression of Dermal Neurofibromas in Neurofibromatosis Type 1 and Relation to NF1 Mutations
A Randomized Placebo-Controlled Study of Lovastatin™ in Children with Neurofibromatosis Type 1
Phase I Trial of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafineb (BAY 43-9006, Nexavar®) in Children and Young Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
Phase II Study of RAD001 (Everolimus) for Children with Neurofibromatosis Type 1 and Chemotherapy Refractory Radiographic Progressive Low-Grade Gliomas
Thursdays, 8:00 a.m.–4:00 p.m.
Kaul Human Genetics Building
720 20th Street South
Birmingham, AL 35294
In some instances, the normal clinic hours can be altered to accommodate a patient's or his or her family's schedule
Make an Appointment
(205) 934-5567 or, toll-free, 1-866-822-4362